Cargando…
Epigenetic pathways and glioblastoma treatment
Glioblastoma multiforme (GBM) is the most common malignant adult brain tumor. Standard GBM treatment includes maximal safe surgical resection with combination radiotherapy and adjuvant temozolomide (TMZ) chemotherapy. Alarmingly, patient survival at five-years is below 10%. This is in part due to th...
Autores principales: | Clarke, Jennifer, Penas, Clara, Pastori, Chiara, Komotar, Ricardo J, Bregy, Amade, Shah, Ashish H, Wahlestedt, Claes, Ayad, Nagi G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883781/ https://www.ncbi.nlm.nih.gov/pubmed/23807265 http://dx.doi.org/10.4161/epi.25440 |
Ejemplares similares
-
Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
por: Tan, Sze Kiat, et al.
Publicado: (2018) -
BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014) -
Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis
por: Stathias, Vasileios, et al.
Publicado: (2014) -
Revisiting the Relationship Between Ethnicity and Outcome in Glioblastoma Patients
por: Shah, Ashish H, et al.
Publicado: (2017) -
The role of awake craniotomy in reducing intraoperative visual field deficits during tumor surgery
por: Wolfson, Racheal, et al.
Publicado: (2015)